News | EP Lab | July 31, 2019

Cardiac Device Complications Vary Widely Among Hospitals

Study out of Australia and New Zealand suggests better reporting, more quality improvement initiatives needed

Cardiac Device Complications Vary Widely Among Hospitals

July 31, 2019 — The chances of patients experiencing complications after having a cardiac device implanted vary according to where they have the procedure.

A study of 174 hospitals in Australia and New Zealand published in the Annals of Internal Medicine shows that the quality of care people receive may account for the wide variation in the rate of complications after having a cardiovascular implantable electronic device (CIED) insertion.

“The study included 81,304 patients who received a new CIED with 65,711 permanent pacemakers and 15,593 implantable cardioverter-defibrillators,” said the study’s lead author, University of Adelaide’s Isuru Ranasinghe, Ph.D., senior cardiologist, Central Adelaide Local Health Network. “Permanent pacemakers and implantable cardioverter-defibrillators are among the most common and costly devices implanted in hospitals.

“CIED complications are common with 8.2 percent of patients implanted with new devices having a major device-related complication within 90 days of their operation. Complications experienced by patients vary between two- and three-fold among hospitals, which suggests that there is significant variation in CIED care quality,” added Ranasinghe

Nearly 19,000 pacemakers and more than 4000 defibrillators were implanted in Australia alone last year. Pacemakers are often fitted to elderly people who suffer from bradycardia where their heart beats too slowly. They use electrical pulses to prompt the heart to beat at a normal rate. Cardioverter-defibrillators track a person’s heart rate, and if an abnormal heart rhythm is detected, the device delivers an electric shock to restore the heart rhythm to normal.

“Serious complications can cause considerable patient harm and adds to avoidable healthcare costs. About 60 percent of these complications occur after leaving the hospital so many doctors and hospitals may not be fully aware of the complications experienced by patients,” said Ranasinghe.

Associate Prof. Anand Ganesan, a study co-investigator and a cardiac electrophysiologist at Flinders Medical Centre said, “What this study really shows is that we should be routinely reporting hospital complication rates to make these fully visible to clinicians, hospitals and the community at large. We should also invest in strategies proven to reduce these, such as optimizing procedural technique, adopting better infection control measures and managing blood thinning drugs peri-procedure.”

Ranasinghe said, “Encouraging hospitals to take part in quality improvement activities such as auditing complications and engaging in clinical quality registries also reduce complications over time.”

This study was funded by the HCF Research Foundation, with additional funding support from the National Heart Foundation of Australia and The Hospital Research Foundation.

For more information: www.annals.org

 

Reference

1. Ranasinghe I., Labrosciano C., Horton D., et al. Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation: A Cohort Study. Annals of Internal Medicine, published online July 30, 2019. DOI: 10.7326/M18-2810


Related Content

Videos | Cardiovascular Clinical Studies

In DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with ...

Home June 12, 2024
Home
News | Cardiovascular Clinical Studies

June 6, 2024 —Cleveland Clinic researchers found higher amounts of the sugar alcohol xylitol are associated with ...

Home June 06, 2024
Home
News | Cardiovascular Clinical Studies

May 31, 2024 — CareDx, a leading precision medicine company focused on the discovery, development, and commercialization ...

Home May 31, 2024
Home
News | Cardiovascular Clinical Studies

May 29, 2024 — Data was presented by AstraZeneca on AZD0780, an oral PCSK9 inhibitor which demonstrated significant LDL ...

Home May 29, 2024
Home
News | Cardiovascular Clinical Studies

May 23, 2024 — A newly-published peer-reviewed study in the Journal of the American Heart Association, JAHA, found that ...

Home May 23, 2024
Home
News | Cardiovascular Clinical Studies

May 23, 2024 — Global Heart Hub, the international alliance of heart patient organizations, announced the first findings ...

Home May 23, 2024
Home
News | Cardiovascular Clinical Studies

May 21, 2024 — A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging ...

Home May 21, 2024
Home
News | Cardiovascular Clinical Studies

May 20, 2024 — Cardiologist Brendan Carry, MD, and a team of Danville, PA-based Geisinger Medical Center physicians have ...

Home May 20, 2024
Home
News | Cardiovascular Clinical Studies

May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ...

Home May 18, 2024
Home
Subscribe Now